NO20023151L - 4-fenyl-1-piperazinyl, -piperidinyl og - tetrahydropyridylderivater - Google Patents

4-fenyl-1-piperazinyl, -piperidinyl og - tetrahydropyridylderivater

Info

Publication number
NO20023151L
NO20023151L NO20023151A NO20023151A NO20023151L NO 20023151 L NO20023151 L NO 20023151L NO 20023151 A NO20023151 A NO 20023151A NO 20023151 A NO20023151 A NO 20023151A NO 20023151 L NO20023151 L NO 20023151L
Authority
NO
Norway
Prior art keywords
phenyl
piperazinyl
piperidinyl
bond
formula
Prior art date
Application number
NO20023151A
Other languages
English (en)
Other versions
NO20023151D0 (no
NO323401B1 (no
Inventor
Benny Bang-Andersen
Jan Kehler
Jakob Felding
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20023151D0 publication Critical patent/NO20023151D0/no
Publication of NO20023151L publication Critical patent/NO20023151L/no
Publication of NO323401B1 publication Critical patent/NO323401B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse omhandler substituerte 4-fenyl-l-piperazinyl derivater som har formelen I. hvori W er C, CH eller N, og den stiplede linjen som utgår fra W indikerer en binding når W er C og ingen binding når W er N eller CH;ogvelges uavhengig fra hydrogen og halogen, forutsatt at minst én av Rog Rer et halogenatom;. X er CH, 0, S, CO, CS, SO eller S0; og. Q er en gruppe med formel (II). forutsatt at X ikke er 0 eller S når gruppen Q er forbundet via et N atom;. og enhver av dens enantiomerer og syreaddisjonssalter derav.Disse forbindelsene har høy affinitet for Dreseptorer.
NO20023151A 1999-12-30 2002-06-28 Halogensubstituerte 4-fenyl-piperazinderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse. NO323401B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901887 1999-12-30
PCT/DK2000/000728 WO2001049679A1 (en) 1999-12-30 2000-12-22 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives

Publications (3)

Publication Number Publication Date
NO20023151D0 NO20023151D0 (no) 2002-06-28
NO20023151L true NO20023151L (no) 2002-08-02
NO323401B1 NO323401B1 (no) 2007-04-23

Family

ID=8108820

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20023151A NO323401B1 (no) 1999-12-30 2002-06-28 Halogensubstituerte 4-fenyl-piperazinderivater, farmasoytiske sammensetninger inneholdende dem og deres anvendelse.
NO20065681A NO20065681L (no) 1999-12-30 2006-12-14 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20065681A NO20065681L (no) 1999-12-30 2006-12-14 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater

Country Status (32)

Country Link
US (2) US7074796B2 (no)
EP (2) EP1464641B1 (no)
JP (1) JP2003519225A (no)
KR (2) KR100729536B1 (no)
CN (2) CN1244577C (no)
AR (1) AR029461A1 (no)
AT (2) ATE269857T1 (no)
AU (2) AU783786B2 (no)
BG (1) BG106960A (no)
BR (1) BR0016953A (no)
CA (1) CA2395869C (no)
CZ (1) CZ20022603A3 (no)
DE (2) DE60011817T2 (no)
DK (2) DK1464641T3 (no)
EA (2) EA005013B1 (no)
ES (2) ES2302992T3 (no)
HK (1) HK1055960A1 (no)
HR (1) HRP20020567A2 (no)
HU (1) HUP0203839A3 (no)
IL (3) IL150366A0 (no)
IS (1) IS6432A (no)
MX (1) MXPA02006590A (no)
NO (2) NO323401B1 (no)
NZ (2) NZ530137A (no)
PL (1) PL355502A1 (no)
PT (2) PT1464641E (no)
SG (1) SG152900A1 (no)
SK (1) SK11072002A3 (no)
TR (2) TR200201690T2 (no)
UA (1) UA73756C2 (no)
WO (1) WO2001049679A1 (no)
ZA (1) ZA200205019B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2311012T3 (es) * 2000-03-27 2009-02-01 ABBOTT GMBH & CO. KG Ligandos del receptor d3 de la dopamina para el tratamiento de la adiccion.
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
FR2831166B1 (fr) 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
ES2251624T3 (es) 2001-12-28 2006-05-01 Acadia Pharmaceuticals Inc. Analogos de la tetrahidroquinolina como los agonistas muscarinicos.
US7550459B2 (en) 2001-12-28 2009-06-23 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
BRPI0417858B1 (pt) * 2003-12-23 2017-10-10 H. Lundbeck A/S Derivative compounds of aniline and pharmaceutical composition that understand it
DE102004027358A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
FR2878524B1 (fr) * 2004-12-01 2007-01-19 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
EP1870405A1 (en) * 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途
CN104725359B (zh) 2013-12-20 2017-05-03 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (no) * 1959-09-25 1900-01-01
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
DE2138865A1 (de) * 1970-08-15 1973-02-22 Sumitomo Chemical Co 3-indolylpiperazine, verfahren zu ihrer herstellung und arzneimittel
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
US4950664A (en) * 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5556857A (en) * 1991-05-08 1996-09-17 Otsuka Pharmaceutical Co., Ltd. Disturbance-of-consciousness improving agent
IT1255178B (it) * 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
US5814644A (en) * 1993-04-15 1998-09-29 Merck Sharp & Dohme, Ltd. Indole derivatives as dopamine D4 antagonists
PT1153603E (pt) * 1993-06-28 2007-01-31 Wyeth Corp Novos tratamentos utilizando derivados de fenetilamina
WO1996017831A1 (de) * 1994-12-07 1996-06-13 Byk Gulden Lomberg Chemische Fabrik Gmbh Uracilderivate
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes
CA2297486C (en) * 1997-08-15 2005-05-03 Pfizer Products Inc. 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
US6355644B1 (en) * 1999-06-14 2002-03-12 Neurogen Corporation Benzylpiperazinyl-indolinylethanones
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
TW580446B (en) * 2003-05-15 2004-03-21 Benq Corp Color electrode array printer

Also Published As

Publication number Publication date
NO20065681L (no) 2002-08-02
DK1246817T3 (da) 2004-10-18
AU2006201000A1 (en) 2006-04-06
NZ530137A (en) 2005-09-30
EA008627B1 (ru) 2007-06-29
KR20070014234A (ko) 2007-01-31
EP1246817B1 (en) 2004-06-23
IS6432A (is) 2002-06-19
IL150366A (en) 2008-06-05
AU783786B2 (en) 2005-12-08
US20060148815A1 (en) 2006-07-06
ES2223628T3 (es) 2005-03-01
BR0016953A (pt) 2003-02-25
DE60011817D1 (de) 2004-07-29
HRP20020567A2 (en) 2005-04-30
KR100729536B1 (ko) 2007-06-18
DK1464641T3 (da) 2008-08-18
JP2003519225A (ja) 2003-06-17
EP1464641A1 (en) 2004-10-06
US7223765B2 (en) 2007-05-29
CN1803784A (zh) 2006-07-19
IL150366A0 (en) 2002-12-01
NO20023151D0 (no) 2002-06-28
BG106960A (bg) 2003-04-30
EP1246817A1 (en) 2002-10-09
KR20020063285A (ko) 2002-08-01
CA2395869A1 (en) 2001-07-12
ATE395333T1 (de) 2008-05-15
TR200201690T2 (tr) 2002-11-21
HK1055960A1 (en) 2004-01-30
TR200402408T4 (tr) 2004-12-21
AU2152701A (en) 2001-07-16
DE60038911D1 (de) 2008-06-26
EA200400641A1 (ru) 2004-10-28
ZA200205019B (en) 2003-09-22
NZ519740A (en) 2004-03-26
PT1246817E (pt) 2004-11-30
EP1464641B1 (en) 2008-05-14
MXPA02006590A (es) 2002-12-13
HUP0203839A2 (hu) 2003-02-28
NO323401B1 (no) 2007-04-23
EA005013B1 (ru) 2004-10-28
PL355502A1 (en) 2004-05-04
SG152900A1 (en) 2009-06-29
CN1244577C (zh) 2006-03-08
EA200200729A1 (ru) 2002-12-26
US20030027832A1 (en) 2003-02-06
CA2395869C (en) 2006-07-25
SK11072002A3 (sk) 2003-03-04
US7074796B2 (en) 2006-07-11
ES2302992T3 (es) 2008-08-01
AR029461A1 (es) 2003-07-02
CN1434819A (zh) 2003-08-06
HUP0203839A3 (en) 2004-07-28
UA73756C2 (en) 2005-09-15
PT1464641E (pt) 2008-07-01
DE60011817T2 (de) 2005-07-14
KR100792186B1 (ko) 2008-01-08
ATE269857T1 (de) 2004-07-15
IL186954A0 (en) 2009-02-11
WO2001049679A1 (en) 2001-07-12
CZ20022603A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
NO20065681L (no) 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater
NO20073720L (no) Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer
SE8503888L (sv) Heterocykliska derivat
ATE368656T1 (de) Piperidinderivate zur verwendung bei der behandlung von durch chemokins vermittelten leiden
TW369533B (en) Quinoline compounds, process for preparing them and pharmaceutical composition containing them
NO20045331L (no) Piperazinylacylpiperidinderivater, deres fremstilling og terapeutisk anvendelse derav
DK0807630T3 (da) Heterocykliske forbindelser
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
NO20023251L (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
TR200402547T4 (tr) Pantoprazol ve ara maddelerini hazırlamak için bir işlem.
DE60230781D1 (en) Reverse hydroxamsäurederivate
DK0579059T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
ATE206125T1 (de) Furoindolizine
MX9703146A (es) Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda.
ES8300707A1 (es) Procedimiento para preparar derivados del acido nicotinico.
IE41394B1 (en) Substituted benimidazoles
NO20010802L (no) Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem
HUP0105018A2 (hu) Eljárás herbicid hatású anellált triazolok előállítására és új anellált triazolok és alkalmazásuk
DE69105108D1 (de) Substituierte N-[Phenyl-(thioxomethyl)]-morpholinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Zusammensetzung und ihre Verwendung.
ATE153338T1 (de) Phosphor enthaltende azetidin-2-on-derivate
ATE86620T1 (de) 7-(1-imidazolyl)-1,4-dihydro-4-oxo-6,8-difluoro 1-cyclopropylchinolincarbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel.
TH53877B (th) สารประกอบเบนโซแลคแทม ที่ถูกแทนที่